- Home
- NERV vs FNKO Comparison
NERV vs FNKO Comparison
Compare NERV & FNKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NERV | FNKO |
|---|---|---|
| Founded | 2007 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.7M | 192.7M |
| IPO Year | 2014 | 2017 |
Fundamental Metrics
Financial Performance| Metric | NERV | FNKO |
|---|---|---|
| Price | $6.31 | $5.22 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $4.00 | ★ $5.50 |
| AVG Volume (30 Days) | 98.5K | ★ 946.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 104.12 | 91.22 |
| EPS | N/A | ★ N/A |
| Revenue | $41,175,600.00 | ★ $1,049,850,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.54 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.15 | $2.22 |
| 52 Week High | $12.46 | $13.54 |
Technical Indicators
Market Signals| Indicator | NERV | FNKO |
|---|---|---|
| Relative Strength Index (RSI) | 69.16 | 75.60 |
| Support Level | $5.66 | $3.52 |
| Resistance Level | $6.69 | $4.06 |
| Average True Range (ATR) | 0.57 | 0.35 |
| MACD | 0.11 | 0.09 |
| Stochastic Oscillator | 84.44 | 99.00 |
Price Performance
Historical ComparisonAbout NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About FNKO Funko Inc.
Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.